Friday, 31st August
Melbourne Immunotherapy Network Winter Retreat 2018
Days
Friday, 31st August
Saturday, 1st September
Search
Speakers
Arrival and registration
12:00PM - 6:30PM
Friday, 31st August
Cuzens Pre Function foyer
Welcome and housekeeping
1:50PM - 2:00PM
Friday, 31st August
Kooringa-Kitchener rooms
Chair: Dale Godfrey
Session 1 - T cell based Cancer Immunotherapy
2:00PM - 3:20PM
Friday, 31st August
Kooringa-Kitchener rooms
Chairs: Paul Beavis &
Clinical priorities in immunotherapy- it’s all about the biology
-
Grant McArthur
Drugging the myeloid-cell kinase HCK improves anti-tumour immunity
-
Ashleigh Poh
Targeting the tumour fibroblastic microenvironment to improve T cell function
-
Anne Fletcher
Treatment Advances in Metastatic Merkel Cell Carcinoma
-
Shahneen Sandhu
Afternoon Tea
3:20PM - 3:45PM
Friday, 31st August
Keppel-Maryland-Cumberland rooms
Session 2 - Anti-viral Immunity/ Autoimmunity
3:45PM - 5:25PM
Friday, 31st August
Kooringa-Kitchener rooms
Chairs: Beatriz Garcillan & Jai Rautela
The role of immune checkpoint blockade in finding a cure for HIV
-
Sharon Lewin
Soluble inhibitory immune checkpoint proteins are elevated in untreated HIV infection
-
Chris Y Chiu
A novel regulator of the type I interferon signalling pathway with broad-spectrum antiviral activity
-
Leon Tribolet
Deletion of TACI protects Lyn-/- mice against autoimmune disease
-
Ee Xin Lim
C-peptide of proinsulin is an autoantigen in human type 1 diabetes
-
Stuart Mannering
Local immunity by Tissue-Resident Memory T cells
-
Laura Mackay
Short Presentation Session 1
5:30PM - 6:00PM
Friday, 31st August
Kooringa-Kitchener rooms
Innate Lymphoid Cells in Melanoma: Promising New Targets for Cancer Treatment.
-
Nicolas Jacquelot
Recognition of non-lipid antigens by CD1d-restricted type 2 NKT cells
-
Catarina Filipa dos Santos Sa e Almeida
Targeting Natural Killer cells via BCL2 inhibition improves stem cell transplant outcomes
-
Joanne Davis
PRMT1 is Required for B-Cell Activation and Differentiation
-
Simona SI Infantino
An immunosuppressive role for IL-11 during tumourigenesis
-
Jennifer Huynh
A novel preclinical platform for evaluating targeted therapy and immunotherapy combinations in BRAF
V600E
melanoma
-
Emily J Lelliott
Welcome Function and Poster Session
6:00PM - 7:00PM
Friday, 31st August
Keppel-Maryland-Cumberland rooms
Exploring the transcriptome of metastatic melanoma to improve natural killer cell targeting
-
Joseph Cursons
Polymorphisims in P2X7 influence post allogeneic stem cell transplantation outcome
-
Joanne Davis
Manipulation of recipient NK cells using Ruxolitinib to target the IL-15 signaling pathway improves allo-HSCT outcomes.
-
Kelei Du
Antibody profiling to predict responses to immunotherapy in melanoma
-
Simone Ostrouska
Dinner
7:30PM - 10:30PM
Friday, 31st August
Radius Restaurant
Saturday →